Join AATB and representatives from several tissue recovery organizations for another interactive case study session. This program will review challenging and complex cases, how issues presented themselves, follow-up actions, and case outcomes. For each case, the audience will respond to the live polls to vote for how they would handle each scenario.

Join AATB and representatives from several tissue recovery organizations for another interactive case study session. This program will review challenging and complex cases, how issues presented themselves, follow-up actions, and case outcomes.

Through this presentation, speakers from multiple tissue processors will review common challenges faced between tissue processors and recovery organizations. We will evaluate challenges in information sharing between processors on multi-tissue donors and recovery organizations.

Through this presentation, speakers from multiple tissue processors will review common challenges faced between tissue processors and recovery organizations. We will evaluate challenges in information sharing between processors on multi-tissue donors and recovery organizations.

Currently, 1.6 M people ages 13+ identify as transgender in the U.S. (according to Williams Institute (ucla.edu). This webinar will discuss working with the LGBTQ+ community, donors, and families. Currently, there are no specific guidelines in place to help us deal with donated tissue from transgender donors. Because misunderstandings about the transgender population still exist, donations may be deferred because of the lack of official guidance. We will provide potential guidance to nonjudgmental screening with a knowledgeable historian, additional screening to assess potential risk factors, treatment/therapy timeframe, and processing considerations. Review of social history can be very subjective, but it is crucial that we assess the risk factors to ensure recipient safety as well as honor the donor’s wish for donation.

Currently, 1.6 M people ages 13+ identify as transgender in the U.S. (according to Williams Institute (ucla.edu). This webinar will discuss working with the LGBTQ+ community, donors, and families. Currently, there are no specific guidelines in place to help us deal with donated tissue from transgender donors. Because misunderstandings about the transgender population still exist, donations may be deferred because of the lack of official guidance. We will provide potential guidance to nonjudgmental screening with a knowledgeable historian, additional screening to assess potential risk factors, treatment/therapy timeframe, and processing considerations. Review of social history can be very subjective, but it is crucial that we assess the risk factors to ensure recipient safety as well as honor the donor’s wish for donation.

Explore what to do with “yes” responses when conducting a donor risk assessment interview using the DRAI. This presentation will dig into the “why” behind key questions on the DRAI by providing insight into how the FDA donor screening criteria were developed, why the DRAI is designed with capture questions, and provide examples of common pitfalls to avoid.